[GOAL] GOAL Digest, Vol 67, Issue 13

Tue Jun 20 20:17:46 BST 2017

Gemma,

Please provide evidence for your statement "an embargo period is needed to
enable the subscription model to continue to operate, in the absence of a
separate business model² other than it sounds like it *probably* should be
true.

We all thought cough medicine should work until someone tested it.

Danny

Dr Danny Kingsley
Head, Office of Scholarly Communication
Cambridge University LibraryWest Road, CB3 9DR
e: dak45 at cam.ac.uk
p: 01223 747 437
m: 07711 500 564
t: @dannykay68
w: www.osc.cam.ac.uk
b: https://unlocking research.blog.lib.cam.ac.uk
o: orcid.org/0000-0002-3636-5939

On 20/06/17 07:27, "goal-bounces at eprints.org on behalf of
goal-request at eprints.org" <goal-bounces at eprints.org on behalf of
goal-request at eprints.org> wrote:

>Send GOAL mailing list submissions to
>	goal at eprints.org
>
>To subscribe or unsubscribe via the World Wide Web, visit
>	http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
>or, via email, send a message with subject or body 'help' to
>	goal-request at eprints.org
>
>You can reach the person managing the list at
>	goal-owner at eprints.org
>
>When replying, please edit your Subject line so it is more specific
>than "Re: Contents of GOAL digest..."
>
>
>Today's Topics:
>
>   1. Re: Elsevier's interpretation of CC BY-NC-ND
>      (Hersh, Gemma (ELS-CAM))
>
>
>----------------------------------------------------------------------
>
>Message: 1
>Date: Tue, 20 Jun 2017 06:17:46 +0000
>From: "Hersh, Gemma (ELS-CAM)" <g.hersh at elsevier.com>
>Subject: Re: [GOAL] Elsevier's interpretation of CC BY-NC-ND
>To: "Global Open Access List (Successor of AmSci)" <goal at eprints.org>
>Message-ID:
>	<CY4PR08MB2838541601FBD60EECB655FE8FC50 at CY4PR08MB2838.namprd08.prod.outlo
>ok.com>
>	
>Content-Type: text/plain; charset="utf-8"
>
>Dear Richard
>
>Elsevier's hosting
>policy<https://www.elsevier.com/about/our-business/policies/hosting>
>explains how platforms can host Elsevier content. This includes enabling
>institutional repositories to share their employee's or student's
>accepted manuscripts publicly after an embargo period, but not beforehand.
>
>The challenge with the proposal below is that it wouldn?t really work
>very well for very long; an embargo period is needed to enable the
>subscription model to continue to operate, in the absence of a separate
>business model.
>
>Best wishes
>
>Gemma
>
>Gemma Hersh
>VP, Policy and Communications
>Elsevier I 125 London Wall I London I EC2Y 5AS
>M: +44 (0) 7855 258 957 I E:
>g.hersh at elsevier.com<mailto:g.hersh at elsevier.com>
>Twitter: @gemmahersh
>
>
>
>
>From: goal-bounces at eprints.org [mailto:goal-bounces at eprints.org] On
>Behalf Of Richard Poynder
>Sent: 18 June 2017 14:30
>To: Global Open Access List (Successor of AmSci) <goal at eprints.org>
>Subject: Re: [GOAL] Elsevier's interpretation of CC BY-NC-ND
>
>
>*** External email: use caution ***
>
>
>On a related topic, this poster might be of interest to list members:
>
>Exploiting Elsevier?s Creative Commons License Requirement to Subvert
>Embargo
>
>"In the last round of author sharing policy revisions, Elsevier created a
>labyrinthine title-by-title embargo structure requiring embargoes from
>12-48 months for author sharing via institutional repository (IR), while
>permitting immediate sharing via author's personal website or blog. At
>the same time, all pre-publication versions are to bear a Creative
>Commons-Attribution-Noncommercial-No Derivatives (CC-BY-NC-ND) license.
>
>"At the time this policy was announced, it was rightly criticized by many
>in the scholarly communication community as overly complicated and
>unnecessary. However, this CC licensing requirement creates an avenue for
>subverting the embargo in the IR to achieve quicker open distribution of
>the author's accepted manuscript.
>
>"In short, authors may post an appropriately licensed copy on their
>personal site, at which point we may deposit without embargo in the IR,
>not through the license granted in the publication agreement, but through
>the CC license on the author's version, which the sharing policy
>mandates. This poster will outline this issue, our experimentation with
>application, and engage viewers in questions regarding its potential
>risks, benefits, and workflows."
>
>https://kuscholarworks.ku.edu/handle/1808/24107
>
>?
>
>
>On 18 June 2017 at 12:24, Mittermaier, Bernhard
><b.mittermaier at fz-juelich.de<mailto:b.mittermaier at fz-juelich.de>> wrote:
>Dear colleagues,
>
>on sharing in file-sharing networks, Creatice Commons explain:
>
>?Can I share CC-licensed material on file-sharing networks?
>Yes. All CC licenses allow redistribution of the unmodified material by
>any means, including distribution via file-sharing networks. Note that
>file-trading is expressly considered to be noncommercial for purposes of
>compliance with the NC licenses. Barter of NC-licensed material for other
>items of value is not permitted.?
>https://creativecommons.org/faq/#can-i-share-cc-licensed-material-on-file-
>sharing-networks
>
>The ?Elsevier Sharing Rules? say
>?CC-BY-NC-ND licensed articles may be shared on non-commercial platforms
>only.?
>http://help.sciencedirect.com/flare/sdhelp_Left.htm#CSHID=password.htm|Sta
>rtTopic=Content%2Fsharing_pubs.htm|SkinName=svs_SD<http://help.sciencedire
>ct.com/flare/sdhelp_Left.htm#CSHID=password.htm%7CStartTopic=Content%2Fsha
>ring_pubs.htm%7CSkinName=svs_SD>
>
>and again in the table at the bottom of that webpage: ?Public posting on
>commercial platforms (e.g.,
>www.researchgate.net<http://www.researchgate.net>,
>www.academia.edu<http://www.academia.edu>)? :not allowed
>
>I?ve been asking Alicia Wise, on what grounds why Elsevier takes that
>position. She replied:
>?Both ResearchGate & academia.edu<http://academia.edu> use content
>commercially to sell advertising & services around the content they
>disseminate? and ?Both ResearchGate &
>academia.edu<https://t.co/IQgdiiCF1s> are problems in Germany as they go
>beyond private use to make NC content publicly available?
>(https://twitter.com/wisealic/status/874284792275140609 and
>https://twitter.com/wisealic/status/874284916644696066 )
>
>My interpretation of the CC licence is that sharing of CC BY-NC-ND
>article by commercial platforms is OK as long as they don?t sell the
>articles (which they don?t do).
>But apart from that - what authors are doing is IMHO definitely not
>prohibited because they have no commercial gain whatsoever.
>
>What do you think?
>
>Kind regards
>Bernhard
>###########################################
>
>Dr. Bernhard Mittermaier
>Forschungszentrum J?lich GmbH
>Leiter der Zentralbibliothek / Head of the Central Library
>52425 J?lich
>Tel  ++49-2461-613013<tel:+49%202461%20613013>
>Fax ++49-2461-616103<tel:+49%202461%20616103>
>
>Sitz der Gesellschaft: Juelich
>Eingetragen im Handelsregister des Amtsgerichts Dueren Nr. HR B 3498
>Vorsitzender des Aufsichtsrats: MinDir Dr. Karl Eugen Huthmacher
>Geschaeftsfuehrung: Prof. Dr.-Ing. Wolfgang Marquardt (Vorsitzender),
>Karsten Beneke (stellv. Vorsitzender), Prof. Dr.-Ing. Harald Bolt,
>Prof. Dr. Sebastian M. Schmidt
>
>
>_______________________________________________
>GOAL mailing list
>GOAL at eprints.org<mailto:GOAL at eprints.org>
>http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
>
>
>
>--
>Richard Poynder
>www.richardpoynder.co.uk<http://www.richardpoynder.co.uk>
>
>________________________________
>
>Elsevier Limited. Registered Office: The Boulevard, Langford Lane,
>Kidlington, Oxford, OX5 1GB, United Kingdom, Registration No. 1982084,
>Registered in England and Wales.
>-------------- next part --------------
>An HTML attachment was scrubbed...
>URL: 
>http://mailman.ecs.soton.ac.uk/pipermail/goal/attachments/20170620/2915b45
>5/attachment.html 
>
>------------------------------
>
>_______________________________________________
>GOAL mailing list
>GOAL at eprints.org
>http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
>
>
>End of GOAL Digest, Vol 67, Issue 13
>************************************